Scientific article
OA Policy
English

Cost-effectiveness of Chagas disease screening in Latin American migrants at primary health-care centres in Europe: a Markov model analysis

Published in

The Lancet Global Health, vol. 5, no. 4, p. e439-e447

Publication date

2017

Abstract

Chagas disease is currently prevalent in European countries hosting large communities from Latin America. Whether asymptomatic individuals at risk of Chagas disease living in Europe should be screened and treated accordingly is unclear. We performed an economic evaluation of systematic Chagas disease screening of the Latin American population attending primary care centres in Europe.

Keywords

  • Antiprotozoal Agents/economics
  • Chagas Disease/diagnosis/economics/ethnology
  • Cost-Benefit Analysis
  • Emigrants and Immigrants/statistics & numerical data
  • Europe/epidemiology
  • Female
  • Humans
  • Latin America/ethnology
  • Male
  • Mass Screening/economics/statistics & numerical data
  • Primary Health Care/economics/organization & administration

Citation (ISO format)

REQUENA-MÉNDEZ, Ana et al. Cost-effectiveness of Chagas disease screening in Latin American migrants at primary health-care centres in Europe: a Markov model analysis. In: The Lancet Global Health, 2017, vol. 5, n° 4, p. e439–e447. doi: 10.1016/S2214-109X(17)30073-6

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

2214-109X
973views
476downloads

Technical informations

Creation

20/02/2018 14:16:00

First validation

20/02/2018 14:16:00

Update

15/03/2023 07:53:18

Status update

15/03/2023 07:53:17

Last indexation

31/10/2024 09:39:37
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated